In utero exposure to levetiracetam vs valproate :Development and language at 3 years of age

Neurology

Volumn 82, Issue 3, 2014, Pages 213-221

  Shallcross, R ^a   Bromley, R L ^a   Cheyne, C P ^a   Garcia Finana M ^a   Irwin, B ^b   Morrow, J ^b   Baker, G A ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL GROUP OF HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETIRACETAM; VALPROIC ACID; ANTICONVULSIVE AGENT; PIRACETAM;

ARTICLE; CHILD; CHILD DEVELOPMENT; COGNITIVE DEVELOPMENT; COMPARATIVE STUDY; COMPREHENSION; CONFIDENCE INTERVAL; CONFOUNDING VARIABLE; CONTROLLED STUDY; EPILEPSY; FEMALE; GESTATIONAL AGE; GRIFFITHS MENTAL DEVELOPMENT SCALE; HUMAN; LANGUAGE ABILITY; LANGUAGE DEVELOPMENT; MALE; MOTOR DEVELOPMENT; MOTOR PERFORMANCE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBSERVATIONAL STUDY; PRENATAL DRUG EXPOSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; REYNELL LANGUAGE DEVELOPAND SCALE; WOMEN WITH EPILEPSY; ADULT; ANALOGS AND DERIVATIVES; DRUG EFFECTS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE; PROSPECTIVE STUDY; UNITED KINGDOM;

ADULT; ANTICONVULSANTS; CHILD DEVELOPMENT; CHILD, PRESCHOOL; EPILEPSY; FEMALE; GREAT BRITAIN; HUMANS; LANGUAGE DEVELOPMENT; MALE; PIRACETAM; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; VALPROIC ACID;

EID: 84895727253     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000030     Document Type: Article

References (29)

1. Bromley RL, Mawer G, Love J, et al. Early cognitive development in children born to women with epilepsy: A prospective report. Epilepsia 2010;51:2058-2065.
2. Tomson T, Battino D, Bonizzoni E, et al. Dose-dependent risk of malformations with antiepileptic drugs: An analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011;10:609-617.
3. Harden CL, Meador KJ, Pennell PB, et al. Management issues for women with epilepsy-focus on pregnancy (an evidence-based review): II: Teratogenesis and perinatal outcomes. Epilepsia 2009;50:1237-1246.
4. Mawhinney E, Craig J, Morrow J, et al. Levetiracetam in pregnancy results from the UK and Ireland epilepsy and pregnancy registers. Neurology 2013;80:400-405.
5. Hernández-Díaz S, Smith CR, Shen A, et al. Comparative safety of antiepileptic drugs during pregnancy. Neurology 2012;78:1692-1699.
6. Isoherranen N, Spiegelstein O, Bialer M, et al. Developmental outcome of levetiracetam, its major metabolite in humans, 2-pyrrolidinone N-butyric acid, and its enantiomer (R)-a-ethyl-oxo-pyrrolidine acetamide in a mouse model of teratogenicity. Epilepsia 2003;44:1280-1288.
7. Ozyurek H, Bozkurt A, Bilge S, Ciftcioglu E, Ilkaya F, Bas DB. Effect of prenatal levetiracetam exposure on motor and cognitive functions of rat offspring. Brain Dev 2010;32:396-403.
8. Ackers R, Besag FMC, Wade A, Murray ML, Wong ICK. Changing trends in antiepileptic drug prescribing in girls of child-bearing potential. Arch Dis Child 2009;94:443-447.
9. Vajda FJE, Hollingworth S, Graham J, et al. Changing patterns of antiepileptic drug use in pregnant Australian women. Acta Neurol Scand 2010;121:89-93.
10. Shallcross R, Bromley RL, Irwin B, Bonnett LJ, Morrow J, Baker GA. Child development following in utero exposure levetiracetam vs sodium valproate. Neurology 2011;76: 383-389.
11. Russell AJC, Craig JJ, Morrison P, et al. UK epilepsy and pregnancy group. Epilepsia 2004;45:1467.
12. Griffiths R. The Abilities of Young Children. Bucks: The Test Agency Limited; 1984.
13. Edwards S, Fletcher P, Garman M, Hughes A, Letts C, Sinka I. The Reynell Development Language Scales, 3rd ed. London: Nelson Publishing Company Limited; 1997.
14. Nelson HE, Willison Jr. National Adult Reading Test (NART). Windsor: NFER-NELSON; 1991.
15. Brace N, Kemp R, Sneglar R. SPSS for Psychologists. 4th ed. New York: Palgrave Macmillan; 2009.
16. Wooldridge JM. Inverse probability weighted estimation for general missing data problems. J Econ 2007;141:1281-1301.
17. Thomas SV, Ajaykumar B, Sindhu K, Nair MK, George B, Sarma PS. Motor and mental development of infants exposed to antiepileptic drugs in utero. Epilepsy Behav 2008;13:229-236.
18. Meador KJ, Baker GA, Browning N, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): A prospective observational study. Lancet Neurol 2013;12:244-252.
19. Bittigau P, Sifringer M, Genz K, et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci USA 2002;99:15089-15094.
20. Manthey D, Asimiadou S, Stefovska V, et al. Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain. Exp Neurol 2005;193:497-503.
21. Kim J, Kondratyev A, Gale K. Antiepileptic drug-induced neuronal cell death in the immature brain: Effects of carbamazepine, topiramate, and levetiracetam as monotherapy versus polytherapy. J Pharmacol Exp Ther 2007;323:165-173.
22. Adab N, Kini U, Vinten J, et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004;75:1575-1583.
23. Kantola-Sorsa E, Gaily E, Isoaho M, et al. Neuropsychological outcomes in children of mothers with epilepsy. J Int Neuropsychol Soc 2007;13:642-652.
24. Nadebaum C, Anderson VA, Vajda F, Reutens DC, Barton S, Wood AG. Language skills of school-aged children prenatally exposed to antiepileptic drugs. Neurology 2011;76:719-726.
25. Bath KG, Scharfman HE. Impact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research. Epilepsy Behav 2013;26:427-439.
26. Cummings C, Stewart M, Stevenson M, Morrow J, Nelson J. Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine. Arch Dis Child 2011;96:643-647.
27. Smith JA, Bidder RT, Gardner SM, Gray OP. Griffiths scales of mental development and different users. Child Care Health Dev 2006;6:11-16.
28. Lynn R. What has caused the Flynn effect? Secular increases in the development quotients of infants. Intelligence 2009;37:16-24.
29. Santos LMd, Santos DNd, Bastos ACS, Assis AMO, Prado MS, Barreto ML. Determinants of early cognitive development: Hierarchical analysis of a longitudinal study. Cad Saúde Pública 2008;24:427-437.